Month: June 2022

Exclusive distribution agreement for initial term of three years Leader Life Sciences commits to minimum purchase of 8 Unyvero systems during initial term    Leader Life Sciences to seek regulatory clearance for Unyvero products in U.A.E. and QatarROCKVILLE, Md., June 09, 2022 (GLOBE NEWSWIRE) — OpGen, Inc. (Nasdaq: OPGN, “OpGen”), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease, announced today that its subsidiary Curetis GmbH has entered into a distribution agreement with Leader Life Sciences via their trading company Leader Medical Supplies Trading LLC, part of the Leader Healthcare Group, for distribution of Unyvero systems in the United Arab Emirates and Qatar. Leader Healthcare Group is one of the Middle East region’s leading distributors and...

PHILADELPHIA, June 09, 2022 (GLOBE NEWSWIRE) — Passage Bio, Inc. (NASDAQ: PASG), a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system disorders, today announced that Simona King, chief financial officer of Passage Bio, will participate in a fireside chat at the upcoming Goldman Sachs 43rd Annual Global Healthcare Conference being held from June 13-16, 2022 in Rancho Palos Verdes, CA. Format: Fireside Chat Date: Thursday, June 16, 2022Time: 8:40 a.m. PT (11:40 a.m. ET) A live webcast of the event will be available on the Investors & Media section of Passage Bio’s website at investors.passagebio.com. A replay of the presentation will be available for 30 days following the events. About Passage Bio Passage Bio (Nasdaq: PASG) is a clinical-stage genetic medicines...

Figure 1 MD-SOQUEM AllianceFigure 2 High Grade Gold DiscoveryFigure 3 Lelievre North-WestFigure 4 Lelievre Showing ExtensionMONTREAL, June 09, 2022 (GLOBE NEWSWIRE) — Midland Exploration Inc. (“Midland”) (TSX-V: MD) is pleased to announce the start of an important exploration program targeting Cu-Zn-Co-Ag-Au / Zn-Pb-Cu-Ag-Au volcanogenic massive sulphides (“VMS”) in the Labrador Trough, Nunavik. This second exploration program will be conducted under the strategic alliance concluded between Midland and SOQUEM       (the “Alliance”). The 2022 exploration program will consist of two phases of prospecting, each lasting three weeks, scheduled from mid-June to mid-August. Several new targets for 2022 and follow-up of 2021 discoveries Following execution of the Alliance, compilation work was undertaken to cover the Labrador...

SAN FRANCISCO, June 09, 2022 (GLOBE NEWSWIRE) — Olema Pharmaceuticals, Inc. (“Olema” or “Olema Oncology,” Nasdaq: OLMA) and Aurigene Discovery Technologies Limited (“Aurigene”) today announced an exclusive global license agreement to research, develop and commercialize novel small molecule inhibitors of an undisclosed oncology target. Under the terms of the agreement, Olema will make an upfront licensing payment of $8 million for rights to a pre-existing Aurigene program. Aurigene will be eligible for up to $60 million in potential clinical development and regulatory milestones and up to $370 million in potential commercial milestones, as well as royalties ranging from the mid-single digits to the low double digits based on annual net sales. During the research term, Olema will contribute funding to Aurigene to facilitate ongoing...

IPA to request a Probiotic FDA Town Hall VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — Wellbeing Digital Sciences Inc. (“Wellbeing” or the “Company”) (NEO: MEDI) (OTC: KONEF) (FRA: SQ2), subsidiary KGK Science Inc. applauds the efforts on the part of U.S. Food and Drug Administration (“FDA” or the “Agency”) to release the recent New Dietary Ingredient (“NDI”) enforcement draft guidance, which is part one of a multipart series of NDI guidance documents the FDA announced during a round table discussion at the IPA World Congress + Probiota Americas. According to FDA, the recent enforcement discretion guidance on late submissions of NDI notifications, released on May 19, 2022, was in response to its commitment in the Fall of 2021 to update guidelines in 2022. Instead of releasing a single guidance document containing...

Co-located Graphene Council Commercialization Conference to highlight materials innovation VANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — HydroGraph Clean Power Inc. (HG.CN) (the “Company” or “HydroGraph”), a commercial manufacturer of high-quality nanomaterials and alternative-energy fuels, has announced today that they will be presenting its innovative graphene product at the upcoming Advanced Materials Show and co-located Graphene Council Commercialization Conference. The shows will take place in Birmingham, UK from Tuesday, June 28-Thursday, June 30. HydroGraph will be featured at Advanced Materials at stand 18-101. Dr. Ranjith Divigalpitiya, HydroGraph chief science officer will lead a roundtable discussion on, “Understanding the Environmental Impact of Graphene-Related Materials.” “We are very excited for the...

Produces highly pure d9-dominant THCV, a non-intoxicating cannabinoid Bolsters Company’s commercial portfolio, which also includes CBDV, CBC and CBT THCV has been researched for a variety of potential benefitsVANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — InMed Pharmaceuticals Inc. (“InMed” or the “Company”) (Nasdaq: INM), a leader in the research, development, manufacturing and commercialization of rare cannabinoids, is pleased to announce it has launched B2B sales of the rare cannabinoid delta 9-dominant tetrahydrocannabivarin (“d9-THCV”) into the health and wellness sector via its wholly-owned subsidiary, BayMedica LLC (“BayMedica”). “We are very excited to launch our highly anticipated d9-THCV and further enhance BayMedica’s growing product portfolio,” stated Shane Johnson, MD, SVP and General Manager of BayMedica....

Figure 1 North Pits Plan ViewFigure 2 Maga Area Resources and Reserve Drilling Plan ViewFigure 3 Maga Area Grade Control Drilling Plan ViewFigure 4 A2 Pit Resources and Reserve Drilling Plan ViewFigure 5 A2 Pit Grade Control Drilling Plan ViewVANCOUVER, British Columbia, June 09, 2022 (GLOBE NEWSWIRE) — Orezone Gold Corporation (TSX: ORE, OTCQX: ORZCF) (the “Company” or “Orezone”) is pleased to report further assay results from the maiden grade control (“GC”) reverse circulation (“RC”) drill program at the Bomboré Gold Project, located in Burkina Faso. GC drilling to-date is focused on near-surface oxide mineralization within the starter pits located in the northern portion of the mining lease. These starter pits will be the source of higher-grade oxide mill feed for the first year of production and are denoted as...